Description

FINDOXIME-CV Dry Syrup contains Cefpodoxime 50 mg and Potassium Clavulanate 31.25 mg, formulated to provide broad-spectrum antibacterial coverage in pediatric patients. Cefpodoxime, a third-generation cephalosporin antibiotic, works by inhibiting bacterial cell wall synthesis, while Potassium Clavulanate acts as a beta-lactamase inhibitor, enhancing the effectiveness of Cefpodoxime against resistant bacteria.

This dry syrup is commonly prescribed for respiratory tract infections, ear, nose and throat infections, urinary tract infections, skin and soft tissue infections, and other susceptible bacterial infections in children. The dry syrup formulation, reconstituted with water, ensures accurate dosing, improved palatability, and better compliance in pediatric use.

Key Highlights:

• Contains Cefpodoxime 50 mg + Potassium Clavulanate 31.25 mg

• Broad-spectrum antibacterial action

• Effective against beta-lactamase–producing bacteria

• Suitable for pediatric bacterial infections

• Easy-to-prepare dry syrup formulation

• Ensures accurate dosing and better compliance

• To be used under medical supervision

Dosage and duration should be followed strictly as prescribed by the physician to ensure safe and effective treatment.

If you want Monopoly PCD Franchise In Panchkula then please contact us.